Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1
- PMID: 20067905
- PMCID: PMC2910332
- DOI: 10.1093/ndt/gfp693
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1
Abstract
We report the development of IgA nephropathy (IgAN) following full myeloablative allogeneic hematopoietic cell transplantation in two patients with human leukocyte antigen (HLA) matched sibling donors, unrelated to active or chronic graft-versus-host disease. Both recipients had elevated urinary levels of galactose-deficient IgA1, and one donor-recipient pair had elevated serum levels of galactose-deficient IgA1. We propose that IgAN developed after bone marrow transplantation due to a non-graft-versus-host-disease-related multi-hit process associated with glomerular deposition of galactose-deficient IgA1. These two cases provide unique insight into the kinetics of overproduction of galactose-deficient IgA1 and its glomerular deposition and consequential renal injury in IgAN.
Figures



References
-
- Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol. 2006;17:1995–2005. - PubMed
-
- Brukamp K, Doyle AM, Bloom RD, et al. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol. 2006;1:685–694. - PubMed
-
- Kimura S, Horie A, Hiki Y, et al. Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma. Blood. 2003;101:4219–4221. - PubMed
-
- Chan GS, Lam MF, Au WY, et al. IgA nephropathy complicating graft-versus-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation. Histopathology. 2004;45:648–651. - PubMed
-
- Moldoveanu Z, Wyatt R, Lee J, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007;71:1148–1154. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DK082753/DK/NIDDK NIH HHS/United States
- R21 DK075868/DK/NIDDK NIH HHS/United States
- DK080301/DK/NIDDK NIH HHS/United States
- DK077279/DK/NIDDK NIH HHS/United States
- R21 DK080301/DK/NIDDK NIH HHS/United States
- R01 DK078244/DK/NIDDK NIH HHS/United States
- DK071802/DK/NIDDK NIH HHS/United States
- R01 DK071802/DK/NIDDK NIH HHS/United States
- R01 DK082753/DK/NIDDK NIH HHS/United States
- DK078244/DK/NIDDK NIH HHS/United States
- DK075868/DK/NIDDK NIH HHS/United States
- R56 DK078244/DK/NIDDK NIH HHS/United States
- R21 DK077279/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous